Subha Madhavan, Ph.D. - Perthera, Inc.

Team Member

Scientific Advisor


Dr. Subha Madhavan, Ph.D., is Director of the Innovation Center for Biomedical Informatics (ICBI) at the Georgetown University Medical Center and Associate Professor of Oncology. She is a world-class leader in data science, clinical informatics and health IT who is responsible for several biomedical informatics efforts including the Georgetown Database of Cancer (G-DOC) a resource for both researchers and clinicians to realize the goals of personalized medicine, the NCI In Silico Research Center for Excellence, and co-directs Lombardi Cancer Center’s Biostatistics and Bioinformatics shared resource. She leads the Biomedical Informatics program of the Georgetown-Howard Universities CTSA. In this role, she has enabled access to more than 2.5 million patient records from 10 MedStar Health hospitals to translational researchers. She was the Principal Investigator on the Breast and Colon Cancer Family Registries data center that coordinates public health and epidemiology data across 12 sites in the US, Australia, and Canada. More recently, she has partnered with the FDA on the Center for Excellence in Regulatory Science program to develop evidence bases for pharmacogenomics and vaccine safety.

Dr. Madhavan has contributed to novel information sciences findings in research articles published in journals such as Nature, Bioinformatics, Molecular and Cell Biology (MCB); AJPM; Frontiers in Oncology, Bioinformatics, Cancer Informatics; and Molecular Cancer Research (MCR). She was also awarded the prestigious Service to America Award for her work as Associate Director of Product and Program Management in the Life Sciences Informatics area at NCI’s Center for Biomedical Informatics and Information Technology where she led a group of scientists, physicians and software engineers in building REMBRANDT (REpository for MolecularBRAin Neoplasia DaTa) – a database that hosts and interconnects clinical data points with various genomics datasets from large brain tumor clinical trials.

Dr. Madhavan has a Master of Science in Information Technology from University of Maryland and a Ph.D. in Molecular Biology and Biological Sciences from the Uniformed Services University for the Health Sciences through a highly ranked Indo-US Collaborative program.